
Scientists have created the first detailed map of how influenza A virus commandeers the machinery inside human cells. The research, published in Nature, reveals specific protein contact points that the virus uses to rewire its host from within.
This is not a study of the virus alone. It is a map of the struggle between virus and cell β a molecular tug-of-war that decides whether you get sick.
The team focused on paraspeckles, tiny structures inside the cell nucleus that help manage stress and process RNA. During infection, the virus hijacks these structures, bending them to its own purposes.
βThe virus doesn't just enter the cell and multiply. It actively reorganises the cell's interior to create a favourable environment for itself,β the researchers explained. The mapping showed how viral proteins latch onto specific host proteins, altering their usual functions.
This hijacking disrupts normal cellular responses, allowing the virus to replicate more efficiently while evading the immune system.
The team used advanced techniques to identify which proteins touch each other during infection. By comparing infected and uninfected cells, they pinpointed changes in the network of protein interactions.
Key findings include the virus targeting proteins involved in RNA splicing and stress granule formation. These processes are critical for the cell's ability to respond to threats. By rewiring them, the virus effectively blinds the cell to its presence.
Understanding these interactions opens a new path for drug development. Instead of attacking the virus directly β which often leads to resistance β drugs could target the host cell mechanisms the virus depends on.
βIf we can block the virus from hijacking paraspeckles, we might stop infection at an early stage,β the authors noted. Such an approach would be harder for the virus to evade.
The study also provides a framework for investigating other viruses. Similar mapping could reveal how SARS-CoV-2, HIV, or dengue virus rewire their hosts.
The next step is to test whether disrupting these protein contacts can prevent infection in animal models. Human trials remain years away, but the molecular map is now in hand.